Institutes
Refine
Year of publication
Document Type
- Doctoral Thesis (311)
- Article (281)
- Preprint (38)
- Contribution to a Periodical (25)
- Book (18)
- Report (2)
Language
- English (520)
- German (154)
- Multiple languages (1)
Has Fulltext
- yes (675)
Is part of the Bibliography
- no (675)
Keywords
- RNA (12)
- SARS-CoV-2 (10)
- NMR spectroscopy (9)
- inflammation (9)
- photochemistry (9)
- NMR (8)
- Biochemistry (7)
- Cell biology (7)
- E2 enzyme (6)
- TRACT (6)
Institute
- Biochemie, Chemie und Pharmazie (675)
- Präsidium (43)
- Medizin (35)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (30)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (30)
- Biowissenschaften (23)
- MPI für Biophysik (15)
- Physik (12)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (5)
- Geowissenschaften / Geographie (4)
- Exzellenzcluster Makromolekulare Komplexe (3)
- Frankfurt Institute for Advanced Studies (FIAS) (3)
- Psychologie und Sportwissenschaften (3)
- Gesellschaftswissenschaften (2)
- MPI für Hirnforschung (2)
- Wirtschaftswissenschaften (2)
- Georg-Speyer-Haus (1)
- Pharmazie (1)
The structure and flexibility of RNA depends sensitively on the microenvironment. Using pulsed electron-electron double-resonance (PELDOR)/double electron-electron resonance (DEER) spectroscopy combined with advanced labeling techniques, we show that the structure of double-stranded RNA (dsRNA) changes upon internalization into Xenopus lævis oocytes. Compared to dilute solution, the dsRNA A-helix is more compact in cells. We recapitulate this compaction in a densely crowded protein solution. Atomic-resolution molecular dynamics simulations of dsRNA semi-quantitatively capture the compaction, and identify non-specific electrostatic interactions between proteins and dsRNA as a possible driver of this effect.
Riboswitch RNAs regulate gene expression by conformational changes induced by environmental conditions and specific ligand binding. The guanidine-II riboswitch is proposed to bind the small molecule guanidinium and to subsequently form a kissing loop interaction between the P1 and P2 hairpins. While an interaction was shown for isolated hairpins in crystallization and electron paramagnetic resonance experiments, an intrastrand kissing loop formation has not been demonstrated. Here, we report the first evidence of this interaction in cis in a ligand and Mg2+ dependent manner. Using single-molecule FRET spectroscopy and detailed structural information from coarse-grained simulations, we observe and characterize three interconvertible states representing an open and kissing loop conformation as well as a novel Mg2+ dependent state for the guanidine-II riboswitch from E. coli. The results further substantiate the proposed switching mechanism and provide detailed insight into the regulation mechanism for the guanidine-II riboswitch class. Combining single molecule experiments and coarse-grained simulations therefore provides a promising perspective in resolving the conformational changes induced by environmental conditions and to yield molecular insights into RNA regulation.
Introduction: In the development of bio-enabling formulations, innovative in vivo predictive tools to understand and predict the in vivo performance of such formulations are needed. Etravirine, a non-nucleoside reverse transcriptase inhibitor, is currently marketed as an amorphous solid dispersion (Intelence® tablets). The aims of this study were 1) to investigate and discuss the advantages of using biorelevant in vitro setups in simulating the in vivo performance of Intelence® 100 mg and 200 mg tablets, in the fed state, 2) to build a Physiologically Based Pharmacokinetic (PBPK) model by combining experimental data and literature information with the commercially available in silico software Simcyp® Simulator V17.1 (Certara UK Ltd.), and 3) to discuss the challenges when predicting the in vivo performance of an amorphous solid dispersion and identify the parameters which influence the pharmacokinetics of etravirine most.
Methods: Solubility, dissolution and transfer experiments were performed in various biorelevant media simulating the fasted and fed state environment in the gastrointestinal tract. An in silico PBPK model for healthy volunteers was developed in the Simcyp® Simulator, using in vitro results and data available from the literature as input. The impact of pre- and post-absorptive parameters on the pharmacokinetics of etravirine was investigated using simulations of various scenarios.
Results: In vitro experiments indicated a large effect of naturally occurring solubilizing agents on the solubility of etravirine. Interestingly, supersaturated concentrations of etravirine were observed over the entire duration of dissolution experiments on Intelence® tablets. Coupling the in vitro results with the PBPK model provided the opportunity to investigate two possible absorption scenarios, i.e. with or without implementation of precipitation. The results from the simulations suggested that a scenario in which etravirine does not precipitate is more representative of the in vivo data. On the post-absorptive side, it appears that the concentration dependency of the unbound fraction of etravirine in plasma has a significant effect on etravirine pharmacokinetics.
Conclusions: The present study underlines the importance of combining in vitro and in silico biopharmaceutical tools to advance our knowledge in the field of bio-enabling formulations. Future studies on other bio-enabling formulations can be used to further explore this approach to support rational formulation design as well as robust prediction of clinical outcomes.
Rhabdomyosarcoma (RMS) is the most frequent pediatric soft-tissue sarcoma comprising two major subtypes – the alveolar and the embryonal rhabdomyosarcoma. The current therapeutic regime is multimodal including surgery, radiation and chemotherapy with cytostatic drugs. Although the prognosis for RMS patients has steadily improved to a 5-year overall survival rate of 70% for ERMS and 50% for ARMS, prognosis for subgroups with primary metastases or relapsed patients is still less than 25%, highlighting the need for development of new therapies for these subgroups. Since cancer cells are addicted to their cancer promoting transcriptional program, remodeling transcription by targeting bromodomain and extraterminal (BET) proteins has emerged as compelling anticancer strategy. However, in many cancer types BET inhibition was proved cytostatic but not cytotoxic emphasizing the need for combination protocols.
In this study we identify a novel synergistic interaction of the BET inhibitor JQ1 with p110α-isoform-specific Phosphoinositid-3-Kinase (PI3K) inhibitor BYL719 (Alpelisib) to induce mitochondrial apoptosis and global reallocation of BRD4 to chromatin. At first, we showed that JQ1 single treatment had cytostatic effects at nanomolar concentrations and inhibited MYC and Hedgehog (Hh) signaling in RMS known to promote proliferation of RMS. However, JQ1 single treatment barely induced cell death in RMS cells even at concentrations of up to 20 µM (< 20% cell death). Thus, we next tested combination approaches to elicit cell death. Since we previously identified synergistic cell death induction of Hh inhibition and PI3K inhibition in RMS cells we tested JQ1 in combination with the pan-PI3K/mTOR inhibitor PI-103 and the p110α-isoform-specific PI3K inhibitor BYL719. In addition, we tested JQ1 in combination with distinct HDAC inhibitors namely JNJ-26481585, SAHA (Vorinostat), MS-275 (Entinostat) and LBH-589 (Panobinostat) since the synergistic interaction of BET and HDAC inhibition has previously been described for other tumor entities.
Interestingly the synergism of cell death induction of JQ1/BYL719 co-treatment is superior to the synergism of JQ1 with pan-PI3K/mTOR inhibitor PI-103 or the tested HDAC inhibitors as confirmed by calculation of combination index. To investigate the molecular mechanisms underlying the synergy of JQ1/BYL719 co-treatment, we performed RNA-Seq and BRD4 ChIP-Seq experiments. RNA-Seq exhibited, that JQ1/BYL719 co-treatment shifted the overall balance of BCL-2 family gene expression towards apoptosis and increased gene expression of proapoptotic BMF, BCL2L11 (BIM) and PMAIP1 (NOXA) while decreasing gene expression of antiapoptotic BCL2L1 (BCL xL). These changes were verified by qRT-PCR and Western blot. Notably, BRD4 is phosphorylated upon JQ1/BYL719 co-treatment and globally reallocates BRD4 to chromatin. This BRD4 reallocation includes enrichment of BRD4 at the super-enhancer site of BMF, at the super-enhancer, typical enhancer and promoter regions of BCL2L11 (BIM) and at the PMAIP1 (NOXA) promoter, while JQ1 alone, as expected, reduces global chromatin binding of BRD4. Integration of RNA-Seq and BRD4 ChIP-Seq data underlines the transcriptional relevance of reallocated BRD4 upon JQ1/BYL719 co-treatment. Immunopreciptation studies showed, that RMS cells are initially primed to undergo mitochondrial apoptosis since BIM is constitutively bound to antiapoptotic BCL-2, BCL xL and MCL-1. JQ1/BYL719 co-treatment increased BIM expression and its neutralization of antiapoptotic BCL-2, BCL-xL and MCL-1 thereby rebalancing the ratio of pro- and antiapoptotic BCL-2 proteins in favor of apoptosis. This promotes activation of BAK and BAX resulting in caspase-dependent apoptosis. The functional relevance of proapoptotic re-balancing for the execution of JQ1/BYL719-mediated apoptosis was confirmed by individual silencing of BMF, BIM, NOXA or overexpression of BCL-2 or MCL-1, which all significantly rescued JQ1/BYL719-induced cell death. Execution of cell death by mitochondrial caspase-dependent apoptosis was veryfied by individual knockdown of BAK and BAX or caspase inhibitor N-Benzyloxycarbonyl-Val-Ala-Asp(O-Me) fluoromethylketone (zVAD.fmk), which all significantly rescued JQ1/BYL719-induced cell death.
In summary, combined BET and PI3Kα inhibition cooperatively induces mitochondrial apoptosis by proapoptotic re-balancing of BCL-2 family proteins accompanied by reallocation of BRD4 to transcriptional regulatory elements of BH3-only proteins.
Dimerization of Taspase1 activates an intrinsic serine protease function that leads to the catalytic Thr234 residue, which allows to catalyze the consensus sequence Q−3X−2D−1⋅G1X2D3D4, present in Trithorax family members and TFIIA. Noteworthy, Taspase1 performs only a single hydrolytic step on substrate proteins, which makes it impossible to screen for inhibitors in a classical screening approach. Here, we report the development of an HTRF reporter assay that allowed the identification of an inhibitor, Closantel sodium, that inhibits Taspase1 in a noncovalent fashion (IC50 = 1.6 μM). The novel inhibitor interferes with the dimerization step and/or the intrinsic serine protease function of the proenzyme. Of interest, Taspase1 is required to activate the oncogenic functions of the leukemogenic AF4-MLL fusion protein and was shown in several studies to be overexpressed in many solid tumors. Therefore, the inhibitor may be useful for further validation of Taspase1 as a target for cancer therapy.
Cardiolipin, the mitochondria marker lipid, is crucially involved in stabilizing the inner mitochondrial membrane and is vital for the activity of mitochondrial proteins and protein complexes. Directly targeting cardiolipin by a chemical-biology approach and thereby altering the cellular concentration of “available” cardiolipin eventually allows to systematically study the dependence of cellular processes on cardiolipin availability. In the present study, physics-based coarse-grained free energy calculations allowed us to identify the physical and chemical properties indicative of cardiolipin selectivity and to apply these to screen a compound database for putative cardiolipin-binders. The membrane binding properties of the 22 most promising molecules identified in the in silico approach were screened in vitro, using model membrane systems finally resulting in the identification of a single molecule, CLiB (CardioLipin-Binder). CLiB clearly affects respiration of cardiolipin-containing intact bacterial cells as well as of isolated mitochondria. Thus, the structure and function of mitochondrial membranes and membrane proteins might be (indirectly) targeted and controlled by CLiB for basic research and, potentially, also for therapeutic purposes.
Hepatocyte nuclear factor 4α (HNF4α) is a ligand-sensing transcription factor and presents as a potential drug target in metabolic diseases and cancer. In humans, mutations in the HNF4α gene cause maturity-onset diabetes of the young (MODY), and the elevated activity of this protein has been associated with gastrointestinal cancers. Despite the high therapeutic potential, available ligands and structure–activity relationship knowledge for this nuclear receptor are scarce. Here, we disclose a chemically diverse collection of orthogonally validated fragment-like activators as well as inverse agonists, which modulate HNF4α activity in a low micromolar range. These compounds demonstrate the druggability of HNF4α and thus provide a starting point for medicinal chemistry as well as an early tool for chemogenomics.
This cumulative dissertation examines learning in chemistry laboratories, focusing on the challenges and benefits of problem-based learning (PBL) for novices in the lab. It addresses the lack of consistent understanding about what should be learned in labs and why it's important. The research aims to understand what students learn, how they learn, and how lab learning can be improved.
A central concept in PBL labs is Information Literacy, defined as a sociocultural practice enabling learners to identify and use information sources within a specific context as legitimized by the practice community.
The first publication, Wellhöfer and Lühken (2022a), investigates the relationship between PBL and learner motivation. It identifies factors that can foster students' intrinsic motivation in a PBL lab. Autonomy is found to be a key factor, increasing student motivation and presenting a model of the autonomous scientific process. This model involves four steps: information acquisition, designing and applying experimental procedures, experimental feedback, and autonomous process optimization. The results suggest that intrinsic motivation in PBL labs can be enhanced by enabling students to independently execute these steps.
The second publication, Wellhöfer and Lühken (2022b), examines the information process students undergo during their first PBL lab. Using a sociocultural framework, it explores Information Literacy to understand students' handling of information and their perceptions of the information process. The findings reveal that in PBL labs, developing a practical, applicable experimental procedure is crucial for problem-solving and significantly shapes the information-acquisition process. This process is iterative, influenced by new information, leading to more precise information needs. Students assess information quality based on its usefulness for their problem, implementability (considering cognitive understanding, available equipment, and psychomotor skills), and safety.
Furthermore, the role of privileged knowledge forms in evaluating the quality of text sources is explored. Students viewed non-scientific sources as "poor" and scientific sources as "good," yet used both for information gathering. There were discrepancies between their assessment of source quality and actual use, indicating that perception of source quality doesn't always affect their practical decisions.
The third publication, Wellhöfer, Machleid, and Lühken (2023), investigates students' information practices in the lab, focusing on discourse between novice learners and experienced assistants. It shows that theoretical knowledge isn't sufficient for independent practical action, and students need actionable social information from experienced community members. The results highlight that information literacy in the lab for newcomers to a community of practice has distinctive features, and physical experience and tacit knowledge are crucial for learning the methods and group-specific knowledge of the practice community. The article demonstrates how learning information literacy in a practice community requires a social and physical experience and provides insights on how educators can support this process.
Large international airports were identified as sources of ultrafine particles (UFPs) (Hu et al., 2009; Yu et al., 2012; Hsu et al., 2013; Keuken et al., 2015; Hudda and Fruin, 2016). Since September 2017 UFP emissions originating from the Frankfurt International Airport, Germany are monitored by the Hessian Agency for Nature Conservation, Environment and Geology (HLNUG) showing elevated UFP concentrations during airport operating hours (05:00–23:00 CET) (Ditas et al., 2022). Referring to that, the organic chemical composition of aviation-related UFPs emerging from the Frankfurt Airport was analysed by performing a comprehensive non-target screening of UFP filter samples.
Aluminium-filter samples were collected at an air quality monitoring station 4 km north of the Frankfurt Airport, using a 13-stage impactor system (Nano-MOUDI). The chemical
characterization of UFPs in the size range of 10-18 nm, 18-32 nm and 32-56 nm was accomplished by ultra-high-performance liquid chromatography, heated electrospray ionisation and mass analysis using an Orbitrap high-resolution mass spectrometer. Non-target screening revealed that the majority of detected compounds belong to homologous series of two different types of organic esters, which are base stocks of aircraft lubrication oils.
In reference to five different jet engine lubrication oils of various manufacturers, the corresponding lubricant base stocks and their additives, two amines and one organophosphate, were identified in the UFPs by the use of matching retention time, exact mass and MS/MS fragmentation pattern of single organic molecules. The quantitative analysis of the jet engine oil constituents in the aviation-related UFPs with diameters < 56 nm was accomplished by standard addition. By characterizing the Nano-MOUDI, loss factors for each size stage were determined and used for correction accordingly. Particle-number size distribution measurements, conducted parallel to the filter sampling, enabled the determination of the jet engine oil contribution to the UFP mass.
Furthermore, the nucleation and particle formation potential of a commonly used synthetic jet engine lubrication oil was investigated in the laboratory. Thermodenuder experiments at 20 °C and 300 °C were carried out to monitor the gas-to-particle partitioning behaviour of jet engine oils. At 300 °C a significantly higher number of particles with a mean diameter of ~10 nm are formed, leading to a more than fivefold increase in total particle numbers compared to 20 °C. Particle diameters of the newly formed oil particles in the laboratory experiment appeared in the same size region as UFPs emerging from Frankfurt Airport. Particles originating from the Frankfurt city centre direction showed larger diameters.
Results indicate that aircraft emissions strongly influence the total mass of 10-18 nm particles. The jet oil fraction decreases for bigger particles (e.g., 18-56 nm), implying that these oils form new particles in the cooling exhaust gases of aircraft engines. In addition, non-target screening and in vitro bioassays on aviation-related PM2.5 filter samples were combined to provide indications for potential toxicologically relevant compounds in dependence of different wind directions and airport operations. Most recently, the applied non-target screening method was also used to identify seasonal variations in the organic aerosol composition in Beijing.
Die humane 5-LO ist das Schlüsselenzym in der LT-Biosynthese. LTs sind wichtige Entzündungsmediatoren und sind in einer Vielzahl von Krankheiten involviert, u. a. Asthma, Atherosklerose, rheumatische Arthritis, Sepsis, allergischen Reaktionen und in vielen Krebsarten. Die Struktur der 5-LO besteht aus 673 Aminosäuren und besitzt ein Molekulargewicht von 78 kDa. Sie ist in zwei Domänen unterteilt: die kleinere C2-ähnliche regulatorische Domäne (C2ld) und der größeren katalytischen Domäne. Die 5-LO besitzt NIS und NES, die für die zelluläre Lokalisation der 5-LO verantwortlich sind. Außerdem wird die Lokalisation noch von Phosphorylierungsstellen reguliert, die auf der katalytischen Domäne identifiziert werden konnten. 2011 konnten Häfner et al. zeigen, dass die 5-LO in der Lage ist Homodimere zu bilden.
Wie für die meisten anderen humanen Gene konnten auch bei der 5-LO alternative Spleißvarianten identifiziert werden. Schon 1992 konnten die ersten unterschiedlich gesüleißten Transkripte in Hirntumoren und differenzierten HL-60-Zellen gefunden werden. Später konnten weitere Isoformen in verschiedenen Zelllinien entdeckt werden.
In der vorliegenden Arbeit wurden die alternativen Spleißvarianten 5-LO∆13, 5-LO∆4 und 5-LOp12 untersucht und charakterisiert. Auf mRNA-Ebene wurde die Expression des 5-LO-WT und deren Isoformen sowohl in B- und T-Zelllinien als auch primären B- und T-Zellen, monozytären Zelllinien und primäre Monozyten aus Patientenproben (RA und Sepsis) untersucht. Es wurde festgestellt, dass das Expressionsprofil der 5-LO-Varianten zellspezifisch ist. Im Vergleich zu den T-Zellen konnte in B-Zelllinien ein höheres Expressionslevel detektiert werden. Des Weiteren zeigte sich interessanterweise ein stark erhöhtes Expressionslevel in primären Monozyten von RA- und Sepsis-Patienten.
Untersuchungen der 5-LO-Aktivität ergaben unterschiedliche Ergebnisse, abhängig von der Transfektionsmethode. Als transiente Transfektion diente die Calciumphosphat-Methode. Für die stabile Integration der HEK293T-Zellen wurde die Sleeping Beauty-Methode gewählt. Hierfür wurden Proteine mit einem GFP bzw. mCherry-Tag (GFP-5-LO-WT, mCherry∆13, mCherry∆4, mCherryp12) verwendet, um diese mittels Konfokalmikroskop visualisieren zu können. Nach transienter Transfektion konnte eine Inhibition der 5-LO-Aktivität nach Kotransfektion mit jeweils einer Isoform gemessen werden. Nach stabiler Integration jedoch zeigte sich eine Steigerung der 5-LO-Produktbildung. Mit Hilfe von Western Blots wurden Expressionskontrollen angefertigt und die Menge des 5-LO-WT quantifiziert. In transient transfizierten Zellen wurde eine Erniedrigung der Expression des 5-LO-WT bestimmt, wohingegen in stabil integrierten Zellen ein Anstieg des 5-LO-WT als auch der Isoformen beobachtet werden konnte. Einerseits könnte dies einem Artefakt der Transfektionmethode zugrunde liegen, andererseits könnte es ein Hinweis darauf sein, dass sich die Proteine gegenseitig in ihrer Expression beeinflussen.
Ebenso wurde die Lokalisation der 5-LO und deren Isoformen untersucht. Es konnte gezeigt werden, dass die 5-LO überwiegend im Zellkern lokalisiert ist, während alle alternativen Protein-Isoformen im Zytosol zu finden waren. Durch Ionophor-Behandlung wurde eine Translokation des 5-LO-WT an die Kernmembran detektiert, die Isoformen verblieben im Zytosol. Überraschenderweise konnte beobachtet werden, dass die Spleißvariante 5-LO∆13 mit höherer Ionophor-Konzentration ebenso in der Lage ist an die Kernmembran zu translozieren. Um eine mögliche Interaktion der 5-LO mit den Isoformen zu untersuchen, sollten alle Proteine im selben Zellkompartiment lokalisiert sein. Dafür wurden verschiedene Stimuli und Mutationen getestet. Mit der Mutante GFP-5-LO-S271A und dem Stressstimulus Sorbitol und den CaMKII/p38-Inhibotoren KN-93/SB203580 konnte eine Translokation in das Zytosol erreicht werden. Die Ergebnisse der anschließenden Aktivitätsassays zeigten, dass die Isoformen keinen Einfluss auf die Aktivität der 5-LO ausüben.
Des Weiteren wurden die Phosphorylierungen an S523 und S271 von 5-LO-WT, 5-LO∆13, 5-LO∆4 und 5-LOp12 untersucht. Es wurde herausgefunden, dass die 5-LO-Proteine unterschiedliche Phosphorylierungsmuster aufweisen. Während 5-LO-WT und 5-LO∆4 eine schwache Phosphorylierung an S271 aufzeigen, konnte eine starke Phosphorylierung der 5-LO∆13 und 5-LOp12 detektiert werden. Im Vergleich dazu zeigte lediglich die Isoform 5-LOp12 eine sehr starke Bande an der Phosphorylierungsstelle S523. Bei beiden Phosphorylierungen konnten deutlich stärkere Signale nach Kotransfektion gemessen werden. Durch Klonierung eines P2A-Linkers zwischen 5-LO und des GFP-Tags, konnten die Isoformen vom 5-LO-WT in Western Blots voneinander getrennt werden. Dies zeigte, dass es zu einer Hochregulation der Expression der alternativen 5-LO-Varianten nach Kotransfektion mit dem WT führte, aber auch, dass die stärkere Phosphorylierung nach Kotransfektion unabhängig von der Proteinmenge ist.